Novo Nordisk A/S
INSULIN DEGLUDEC IN CARDIOVASCULAR CONDITIONS
Last updated:
Abstract:
The present invention relates to insulin degludec for use in medicine.
Status:
Application
Type:
Utility
Filling date:
8 Feb 2022
Issue date:
26 May 2022